National Institute of Allergy and Infectious Diseases

WASHINGTON — A temperature-stable, experimental tuberculosis vaccine has been found safe and effective in a clinical phase 1 trial involving healthy adults conducted by the National Institute of Allergy and Infectious Diseases. A non-temperature stable form of the candidate previously... Read More

WASHINGTON — An experimental vaccine against Marburg virus, a member of the Ebola virus family that causes death in a large proportion of infected individuals, proved safe and induced an immune response in a small, first-in-human clinical trial. The findings... Read More

WASHINGTON — An experimental therapeutic cancer vaccine induced two distinct and desirable immune system responses that led to significant tumor regression in mice, according to investigators from the National Institute of Allergy and Infectious Diseases.  The experimental vaccine, SNAPvax, was... Read More

WASHINGTON — Dr. Anthony Fauci, who in many ways was the face of the nation’s response to the coronavirus pandemic, announced Monday he will be stepping down from his roles as chief medical advisor to President Joe Biden and director... Read More